Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Prime Minister Justin Trudeau takes part in a news conference in Ottawa, on Nov. 6, 2020.

PATRICK DOYLE/Reuters

Prime Minister Justin Trudeau said Monday he hopes to see COVID-19 vaccines roll out in Canada early next year, but warned that won’t bring an immediate resolution to the pandemic currently seeing a resurgence in several provinces.

The prime minister said news from Pfizer that one of its vaccine candidates appears very effective in clinical trials is “very encouraging” but won’t help anyone who catches the virus in the meantime.

Speaking in Ottawa, Trudeau said other vaccine candidates have also appeared to progress well, and Canada has secured access to several, given the uncertainty regarding which will be ready first, which will be more effective with certain populations, and other variables.

Story continues below advertisement

When a vaccine is safe to distribute, the government will begin dispensing it to high-priority groups first, he said.

“We hope to see vaccines landing in the early next year but between now and then it’s really, really important that we double down on our efforts,” Trudeau said.

“We need to make sure we are controlling the spread of COVID-19 in the coming months so that when vaccines get here we will be able to act quickly to protect all Canadians.”

His comments came after a weekend that saw the two provinces hardest hit by the pandemic report record-breaking daily case counts.

Quebec and Ontario reported 1,397 and 1,328 new cases respectively on Sunday, followed by 1,169 and 1,242 on Monday.

Health officials in Quebec said Monday that while the situation has improved in some parts of the province, such as Quebec City and Montreal, it is worsening in others – including the Saguenay-Lac-St-Jean area, which currently has more than double the provincial rate of cases per 100,000 people.

Public health authorities reported 94 new cases in the region on Monday, for a total of 312 active cases per 100,000 people.

Story continues below advertisement

The region was placed under Quebec’s highest COVID-19 alert level on Nov. 2, and the province’s health minister said it will take some time before any effects from the new restrictions are seen.

In Ontario, Premier Doug Ford was asked Monday whether the ballooning cases in the province pushed him to reconsider its new colour-coded system for pandemic measures, which loosened public health restrictions in all regions but Toronto when it took effect Saturday.

The tiered system places health units in colour-coded categories based on their caseload and transmission levels, and has drawn criticism for allowing activities such as indoor dining in restaurants in all alert levels short of a lockdown.

In Peel Region, the only area currently in the red category, local health officials imposed additional measures over the weekend in order to reduce the risk of transmission.

But Ford defended the system Monday, saying it was built to give each region the flexibility to enact further rules, as Peel did. “That’s the reason we have the framework,” he said.

Toronto, meanwhile, is remaining under a previous, more stringent system until the end of the week, at the request of local officials. The city accounted for 483 of Ontario’s new cases on Monday.

Story continues below advertisement

Mayor John Tory said the city would likely follow in Peel Region’s footsteps and impose “an enhanced suite of measures” to stem the spread of the virus, with more details to come Tuesday.

The city’s top doctor, Dr. Eileen de Villa, said the COVID-19 numbers seen over the last few days were among the “most concerning” she’s seen since the start of the pandemic.

Further west, Manitoba reported 365 new COVID-19 cases Monday as it continued to lead the country in per-capita active cases.

Chief public health officer Dr. Brent Roussin said the province is at a critical point in time, pointing to increased strain on the health system.

Roussin said he has talked with Premier Brian Pallister about imposing further restrictions.

Meanwhile, Trudeau said the federal government is already working on the logistics of distributing a COVID-19 vaccine, particularly since the Pfizer candidate needs to be stored at around -75C to remain stable.

Story continues below advertisement

Canada has bought the rights to 20 million doses of Pfizer’s vaccine, if it proves effective and Health Canada approves it for use here, and Trudeau said the government would purchase more if the initial round goes well.

The company said in a news release that early results from a large-scale trial show its vaccine is 90 per cent effective at combating the virus.

Prime Minister Justin Trudeau expressed optimism about early results for a new COVID-19 vaccine developed by Pfizer, saying there is now 'light at the end of the tunnel' when it comes to the pandemic. The Canadian Press

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you manage your health, your finances and your family life as Canada reopens.
Visit the hub
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies